
    
      Primary Objective: To assess clinical complete response of an organ preservation approach
      using short course radiation followed by intensified chemotherapy.

      Secondary Objective: To assess safety in all enrolled patients, local regrowth rate and other
      cancer specific outcomes (metastasis-free survival, colostomy-free survival and overall
      survival), longitudinal health-related quality of life of this organ preservation approach
    
  